1. Home
  2. MDV vs NKTX Comparison

MDV vs NKTX Comparison

Compare MDV & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDV
  • NKTX
  • Stock Information
  • Founded
  • MDV 2015
  • NKTX 2015
  • Country
  • MDV United States
  • NKTX United States
  • Employees
  • MDV N/A
  • NKTX N/A
  • Industry
  • MDV Transportation Services
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDV Consumer Discretionary
  • NKTX Health Care
  • Exchange
  • MDV Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • MDV 147.6M
  • NKTX 123.5M
  • IPO Year
  • MDV 2022
  • NKTX 2020
  • Fundamental
  • Price
  • MDV $14.27
  • NKTX $1.67
  • Analyst Decision
  • MDV
  • NKTX Strong Buy
  • Analyst Count
  • MDV 0
  • NKTX 6
  • Target Price
  • MDV N/A
  • NKTX $14.40
  • AVG Volume (30 Days)
  • MDV 107.6K
  • NKTX 505.0K
  • Earning Date
  • MDV 08-05-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • MDV 8.30%
  • NKTX N/A
  • EPS Growth
  • MDV N/A
  • NKTX N/A
  • EPS
  • MDV N/A
  • NKTX N/A
  • Revenue
  • MDV $46,738,000.00
  • NKTX N/A
  • Revenue This Year
  • MDV $2.21
  • NKTX N/A
  • Revenue Next Year
  • MDV $4.45
  • NKTX N/A
  • P/E Ratio
  • MDV N/A
  • NKTX N/A
  • Revenue Growth
  • MDV N/A
  • NKTX N/A
  • 52 Week Low
  • MDV $13.62
  • NKTX $1.31
  • 52 Week High
  • MDV $18.11
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • MDV 44.01
  • NKTX 39.70
  • Support Level
  • MDV $14.01
  • NKTX $1.70
  • Resistance Level
  • MDV $14.73
  • NKTX $1.84
  • Average True Range (ATR)
  • MDV 0.31
  • NKTX 0.09
  • MACD
  • MDV 0.02
  • NKTX -0.02
  • Stochastic Oscillator
  • MDV 17.20
  • NKTX 2.38

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: